BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Molina MF, Abdelnabi MN, Fabre T, Shoukry NH. Type 3 cytokines in liver fibrosis and liver cancer. Cytokine 2019;124:154497. [DOI: 10.1016/j.cyto.2018.07.028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Liu Z, Liu L, Huang M, Huang Y. Th22/IL-22 mediates the progression of HBV-related hepatocellular carcinoma via STAT3. Cytotechnology. [DOI: 10.1007/s10616-021-00517-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Gobran ST, Ancuta P, Shoukry NH. A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection. Front Immunol 2021;12:726419. [PMID: 34456931 DOI: 10.3389/fimmu.2021.726419] [Reference Citation Analysis]
3 Sutti S, Albano E. Adaptive immunity: an emerging player in the progression of NAFLD. Nat Rev Gastroenterol Hepatol 2020;17:81-92. [PMID: 31605031 DOI: 10.1038/s41575-019-0210-2] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 33.3] [Reference Citation Analysis]
4 Jiang R, Sun B. IL-22 Signaling in the Tumor Microenvironment. Adv Exp Med Biol 2021;1290:81-8. [PMID: 33559856 DOI: 10.1007/978-3-030-55617-4_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li L, Yang L, Liu F, Qu J. Exploration of the Molecular Mechanism of Danzhi Xiaoyao Powder in Endometrial Cancer through Network Pharmacology. Evid Based Complement Alternat Med 2022;2022:8330926. [PMID: 35774749 DOI: 10.1155/2022/8330926] [Reference Citation Analysis]
6 Torre P, Motta BM, Sciorio R, Masarone M, Persico M. Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System. Front Med (Lausanne) 2021;8:781567. [PMID: 34957156 DOI: 10.3389/fmed.2021.781567] [Reference Citation Analysis]
7 Biagioli M, Fiorucci S. Bile acid activated receptors: Integrating immune and metabolic regulation in non-alcoholic fatty liver disease. Liver Research 2021;5:119-41. [DOI: 10.1016/j.livres.2021.08.003] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Le Vée M, Bruyère A, Jouan E, Fardel O. Janus kinase-dependent regulation of drug detoxifying protein expression by interleukin-22 in human hepatic cells. International Immunopharmacology 2020;83:106439. [DOI: 10.1016/j.intimp.2020.106439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Fiorucci S, Zampella A, Ricci P, Distrutti E, Biagioli M. Immunomodulatory functions of FXR. Mol Cell Endocrinol 2022;551:111650. [PMID: 35472625 DOI: 10.1016/j.mce.2022.111650] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Fabre T, Molina MF, Soucy G, Goulet J, Willems B, Villeneuve J, Bilodeau M, Shoukry NH. Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis. Sci Immunol 2018;3:eaar7754. [DOI: 10.1126/sciimmunol.aar7754] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 10.8] [Reference Citation Analysis]
11 Su G, Li Z, Wang R, Lu Y, Nan J, Wu Y, Zhao Y. Signaling pathways involved in p38-ERK and inflammatory factors mediated the anti-fibrosis effect of AD-2 on thioacetamide-induced liver injury in mice. Food Funct 2019;10:3992-4000. [DOI: 10.1039/c8fo02405g] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
12 Zai W, Chen W, Liu H, Ju D. Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications. Biomedicines 2021;9:1912. [PMID: 34944732 DOI: 10.3390/biomedicines9121912] [Reference Citation Analysis]
13 Li S, Song F, Lei X, Li J, Li F, Tan H. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging (Albany NY) 2020;12:11517-29. [PMID: 32584784 DOI: 10.18632/aging.103257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]